M S Marshall

Author PubWeight™ 75.89‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cloning of bovine GAP and its interaction with oncogenic ras p21. Nature 1988 5.56
2 Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1. Nature 1993 4.88
3 PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature 1989 4.36
4 Sequence dependence of protein isoprenylation. J Biol Chem 1991 3.10
5 S. cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell 1990 3.09
6 The protein kinase Pak3 positively regulates Raf-1 activity through phosphorylation of serine 338. Nature 1998 2.93
7 CDC25: a component of the RAS-adenylate cyclase pathway in Saccharomyces cerevisiae. Science 1987 2.67
8 Modulation of guanine nucleotides bound to Ras in NIH3T3 cells by oncogenes, growth factors, and the GTPase activating protein (GAP). J Biol Chem 1990 2.49
9 The Differentiation of Hemolytic Streptococci from Various Sources by the Group Precipitin Reaction and by Biochemical Tests. J Bacteriol 1940 2.24
10 The ras oncogene--an important regulatory element in lower eucaryotic organisms. Microbiol Rev 1989 1.79
11 Identification of guanine nucleotides bound to ras-encoded proteins in growing yeast cells. J Biol Chem 1987 1.74
12 Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase. J Biol Chem 1990 1.68
13 Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338. Curr Biol 2000 1.60
14 Preferential inhibition of the oncogenic form of RasH by mutations in the GAP binding/"effector" domain. Cell 1991 1.57
15 Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues. Mol Cell Biol 1994 1.56
16 Adsorption of Bacteria by Inert Particulate Reagents. J Bacteriol 1937 1.54
17 Regulatory function of the Saccharomyces cerevisiae RAS C-terminus. Mol Cell Biol 1987 1.51
18 Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. Carcinogenesis 2000 1.51
19 An intact Raf zinc finger is required for optimal binding to processed Ras and for ras-dependent Raf activation in situ. Mol Cell Biol 1997 1.37
20 Ras interaction with the GTPase-activating protein (GAP). Proteins 1989 1.35
21 Protein isoprenylation in suspension-cultured tobacco cells. Plant Cell 1993 1.28
22 Pancreatic tumor cells with mutant K-ras suppress ERK activity by MEK-dependent induction of MAP kinase phosphatase-2. Biochem Biophys Res Commun 2001 1.28
23 Interferon-inducible protein 10 and macrophage inflammatory protein-1 alpha inhibit growth factor stimulation of Raf-1 kinase activity and protein synthesis in a human growth factor-dependent hematopoietic cell line. J Biol Chem 1995 1.20
24 Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Curr Biol 2000 1.17
25 Substrate characterization of the Saccharomyces cerevisiae protein farnesyltransferase and type-I protein geranylgeranyltransferase. Biochim Biophys Acta 1994 1.17
26 The ubiquitously expressed Syp phosphatase interacts with c-kit and Grb2 in hematopoietic cells. J Biol Chem 1994 1.13
27 Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem J 2000 1.10
28 Lack of elevated MAP kinase (Erk) activity in pancreatic carcinomas despite oncogenic K-ras expression. Int J Oncol 1999 1.06
29 CDC43 and RAM2 encode the polypeptide subunits of a yeast type I protein geranylgeranyltransferase. J Biol Chem 1992 1.03
30 Cell cycle effects of nonsteroidal anti-inflammatory drugs and enhanced growth inhibition in combination with gemcitabine in pancreatic carcinoma cells. J Pharmacol Exp Ther 2001 1.02
31 Phosphorylation site specificity of the Pak-mediated regulation of Raf-1 and cooperativity with Src. FEBS Lett 2001 1.01
32 Role of GTPase activating protein in mitogenic signalling through phosphatidylcholine-hydrolysing phospholipase C. EMBO J 1991 1.00
33 Structure/function studies of the ras protein. Cold Spring Harb Symp Quant Biol 1988 0.96
34 Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression function. Br J Cancer 2004 0.91
35 In vitro inhibition of Ras-Raf association by short peptides. Biochem Biophys Res Commun 1998 0.90
36 p120 Ras GTPase-activating protein interacts with Ras-GTP through specific conserved residues. J Biol Chem 1996 0.90
37 Interleukin-11 induces complex formation of Grb2, Fyn, and JAK2 in 3T3L1 cells. J Biol Chem 1995 0.85
38 Use of an enzyme-linked immunosorbent assay to measure antibody responses in turkeys against Pasteurella multocida. Avian Dis 1982 0.85
39 Amino acid residues that define both the isoprenoid and CAAX preferences of the Saccharomyces cerevisiae protein farnesyltransferase. Creating the perfect farnesyltransferase. J Biol Chem 1998 0.82
40 Structure/function relationships of ras and guanosine triphosphatase-activating protein. Soc Gen Physiol Ser 1990 0.80
41 Reconstitution of interactions between the Src tyrosine kinases and Ras GTPase-activating protein using a baculovirus expression system. J Biol Chem 1992 0.80
42 Mutational analysis of the beta-subunit of yeast geranylgeranyl transferase I. Mol Gen Genet 1996 0.80
43 Macrophage inflammatory protein-1 alpha enhances growth factor-stimulated phosphatidylcholine metabolism and increases cAMP levels in the human growth factor-dependent cell line M07e, events associated with growth suppression. J Immunol 1995 0.80
44 Transformation of interleukin-3-dependent cells without participation of Stat5/bcl-xL: cooperation of akt with raf/erk leads to p65 nuclear factor kappaB-mediated antiapoptosis involving c-IAP2. Blood 2001 0.79
45 Ras-Raf complexes in vitro. Methods Enzymol 1995 0.78
46 Mutagenesis and biochemical analysis of recombinant yeast prenyltransferases. Methods Enzymol 1995 0.77
47 Involvement of H-ras in erythroid differentiation of TF1 and human umbilical cord blood CD34 cells. Blood Cells Mol Dis 1998 0.77
48 The ras oncogene protein as a G-protein. Adv Second Messenger Phosphoprotein Res 1988 0.77
49 Genetic analysis of the molecular basis for beta-adrenergic receptor subtype specificity. Proteins 1989 0.76
50 THE MERTHIOLATE-A NEW ANTISEPTIC. Cal West Med 1931 0.75
51 CENTRIFUGING FILTERABLE VIRUSES. Science 1927 0.75
52 Spherical particle sizing based on the VanderLugt correlator. Appl Opt 1991 0.75
53 Brucella in Commercial Milk Supplies. Cal West Med 1931 0.75
54 Immunity in Diphtheria. Cal West Med 1932 0.75
55 Serum Preservatives. Cal West Med 1934 0.75
56 Control of turkey Alcaligenes rhinotracheitis in Utah with a live vaccine. Avian Dis 1982 0.75
57 The teaching laboratories. J Med Educ 1973 0.75
58 Ethics, Law, and the Universities. Science 1964 0.75
59 The roots of health. Koku Eisei Gakkai Zasshi 1972 0.75
60 Bridge sciences. J Med Educ 1973 0.75
61 Characterization of the Ras binding domain of the RalGDS-related protein, RLF. Biochem Biophys Res Commun 1997 0.75
62 Classicists and Structural Linguists. Science 1962 0.75
63 Spherical particle sizing by optical correlation using ternary phase-amplitude filters. Appl Opt 1992 0.75
64 The concept of prevention. Koku Eisei Gakkai Zasshi 1972 0.75
65 In Vitro Studies of Caries oof the Enamel in the Syrian Hamster. Science 1948 0.75
66 The effects of deep physical relaxation and low-frequency-alpha brainwaves on alpha subjective reports. Psychophysiology 1976 0.75
67 Letters to the Editor. Science 1964 0.75
68 Immunologic. Science 1948 0.75
69 Questions and Answers. Science 1962 0.75
70 Adjustable standards. J Dent Educ 1969 0.75
71 Letter to the Editor. Science 1962 0.75